• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Niagen Bioscience Inc (NAGE)

Common Shares
Sell: $7.34|Buy: $7.44|Change: 0.08 (-1.07%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

Find out more

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Address

10900 Wilshire Boulevard
Suite 650
Los Angeles
CA
USA
90024

Telephone

+1 310 388-6706

Website

https://www.niagenbioscience.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Niagen Bioscience Inc Second Quarter Earnings Conference Call for 20262026-08-06T16:30:00
Niagen Bioscience Inc Second Quarter Earnings Results for 20262026-08-06T00:00:00
Niagen Bioscience Inc Annual General Meeting for 20262026-06-24T15:00:00
Niagen Bioscience Inc First Quarter Earnings Conference Call for 20262026-05-07T16:30:00
Niagen Bioscience Inc First Quarter Earnings Results for 20262026-05-07T00:00:00
ChromaDex Corp Fourth Quarter Earnings Conference Call for 20252026-03-04T16:30:00
ChromaDex Corp Fourth Quarter Earnings Results for 20252026-03-04T00:00:00
ChromaDex Corp Annual Report for 20252026-03-04T00:00:00
ChromaDex Corp Third Quarter Earnings Conference Call for 20252025-10-31T16:30:00
ChromaDex Corp Third Quarter Earnings Results for 20252025-10-31T00:00:00

Previous key dates

NameKey Date
ChromaDex Corp Third Quarter Earnings Conference Call for 20252025-10-31T16:30:00
ChromaDex Corp Third Quarter Earnings Results for 20252025-10-31T00:00:00
CG 45th Annual Growth Conference2025-08-12T12:00:00
Niagen Bioscience Inc Second Quarter Earnings Conference Call for 20252025-08-06T16:30:00
Niagen Bioscience Inc Second Quarter Earnings Results for 20252025-08-06T00:00:00
Niagen Bioscience Inc Annual General Meeting for 20252025-06-24T15:00:00
Niagen Bioscience Inc First Quarter Earnings Conference Call for 20252025-05-07T16:30:00
Niagen Bioscience Inc First Quarter Earnings Result for 20252025-05-07T00:00:00
ChromaDex Corp Fourth Quarter Earnings Conference Call for 20242025-03-04T16:30:00
ChromaDex Corp Fourth Quarter Earnings Result for 20242025-03-04T00:00:00
ChromaDex Corp Annual Report for 20242025-03-04T00:00:00
Lytham Partners 2025 Investor Healthcare Summit2025-01-13T12:00:00
ChromaDex Corp Third Quarter Earnings Conference Call for 20242024-10-31T16:30:00
ChromaDex Corp Third Quarter Earnings Results for 20242024-10-31T00:00:00
ChromaDex to Participate in the 17th Annual LD Micro Main Event2024-10-29T14:00:00
ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference2024-10-01T13:15:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.